Nobel Prize in Chemistry 2026 Awarded for Groundbreaking Discovery
The 2026 Nobel Prize in Chemistry has been awarded to the French chemist Henri B. Kagan and the Japanese scientist Kensō Soai for their significant contribution to solving the enigma of chemical asymmetry in nature. This groundbreaking discovery has paved the way for innovative approaches to manipulate reactions essential in the production of pharmaceuticals, fragrances, and various materials.
The research conducted by Kagan and Soai delves into one of the most enigmatic chemical phenomena, known as homochirality. This term refers to chiral molecules, which exist in two mirror-image variants, with only one of these forms being predominantly present in living organisms. These mirror-image molecules, termed enantiomers, exhibit similar physical properties but can behave differently in biological contexts. To illustrate this concept, the Nobel Committee provided a relatable analogy: “Imagine you are a locksmith making custom keys. The challenge is that every time you produce a key, you end up with two identical copies, but only one fits the lock; furthermore, attempting to use the other key may damage the lock. Unfortunately, distinguishing between the keys proves to be quite difficult, so the customer ends up taking both.”
Understanding the Mystery of Chirality in Nature
Saúl Alberca Manzano, a professor in the Department of Organic and Pharmaceutical Chemistry at the University of Seville, elaborated on the implications of this discovery for SMC España, stating, “Our DNA and proteins exhibit chiral properties, offering two possibilities; they are molecules that rotate light in one direction or the other, and understanding why one exists over the other has been a mystery. These two researchers have unlocked the secret behind nature’s homochirality.”
In the realm of drug development, particularly those based on amino acids or sugar molecules, homochirality poses a significant challenge. While one enantiomer of these chiral molecules may produce the desired therapeutic effect, the other could lead to unnecessary and sometimes harmful side effects.
The Historical Context of Chiral Molecules
The discovery of chiral molecules can be traced back to the work of Louis Pasteur, who identified two forms of tartaric acid that were mirror images of each other, which reacted oppositely when exposed to certain bacteria. Since then, numerous researchers have endeavoured to replicate homochirality in laboratory settings to understand its spontaneous origins and to apply this knowledge in designing controlled reactions for various applications. However, early experiments yielded equal amounts of both variants, failing to replicate the selectivity observed in nature.
In the early 20th century, the German chemist Willy Marckwald developed an asymmetric reaction that produced a slightly higher yield of one variant over the other, utilising a chiral catalyst—a substance that facilitates a chemical reaction without being consumed while promoting the formation of one of the enantiomers. However, the disparity between the two variants remained minimal.
Advancements in Asymmetric Reactions
By 1953, theoretical physicist Charles Frank proposed a mathematical model outlining three conditions necessary for replicating homochirality: there must be an asymmetric reaction that favours one of the two variants; this imbalance should be amplified; and the reaction itself should produce the catalyst that drives it. This last characteristic, known as autocatalysis, creates a positive feedback loop, where a slight initial advantage can lead to one variant increasing at an accelerating rate until it dominates the reaction.
These foundational ideas formed the basis of Henri Kagan’s research, which began in the early 1980s as he sought to refine asymmetric reactions through a detailed study of catalysts. At that time, scientists typically employed catalysts comprised of a metal atom that acted as the reaction engine and a chiral substance to ensure the process was asymmetric. They believed that using a mixture with equal amounts of both versions of a chiral molecule would yield a balanced result.
Innovative Discoveries in Reaction Mechanisms
Kagan began to challenge this assumption, realising that the metal atom likely interacted with two chiral molecules simultaneously. This meant that mixing versions A and B could produce three different combinations: A-A, B-B, and B-A. The first two combinations would yield mirror-image molecules, but the A-B combination was distinct and could behave differently during the reaction. Kagan discovered that the combination B-A could inhibit the reaction, thereby indirectly favouring the formation of one of the two final molecule variants. This phenomenon, termed the “non-linear effect,” represented a novel method for manipulating chemical reactions.
“In addition to their practical interest, non-linear effects provide a valuable tool for studying reaction mechanisms and the nature of catalytically active species,” noted José María Andrés García, a professor in the Department of Organic Chemistry at the University of Valladolid, in a statement referenced by SMC España.
Soai’s Breakthrough in Catalytic Reactions
Building on Kagan’s findings, Kensō Soai contemplated whether it would be feasible to create a reaction where the product itself acted as a catalyst, facilitating the production of more identical molecules and generating a preferential trend toward one of the two mirror-image versions of a molecule. Soai conducted experiments with a substance known as 5-pyrimidylalkanol, beginning with only a 2% advantage of one molecular variant. Remarkably, after the reaction, this advantage surged to 87%.
In subsequent years, Soai continued his research to achieve the near-absolute purity characteristic of many molecules found in living organisms. Ultimately, in 2003, he presented a reaction in which substances lacking a defined orientation randomly yielded a small amount of one variant. This slight difference could be exploited to produce significantly more molecules of the same form. Gradually, one variant came to dominate the reaction, potentially comprising 99.99% of the final product.
Significance of the Nobel-Winning Research
In essence, the reaction resulted in the formation of only one of the two possible mirror-image versions. “Apart from life itself, no one had previously achieved such a feat. Thanks to Henri Kagan and Kensō Soai, we now understand how homochirality can arise. Their discoveries have been crucial for chemists designing reactions for the production of pharmaceuticals,” concluded the Nobel Committee.
